Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Pietschmann

Showing results (171-180 of 210) with videos related to

Pageof 21
Sort By:
Hepatology (Baltimore, Md.)|May 23, 2015
Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of membranous web formationAnggakusuma, Inés Romero-Brey, Carola Berger, et al.
Hepatology Communications|February 7, 2018
Hepatitis E virus replication and interferon responses in human placental cellsLeonard Knegendorf, Svenja A Drave, Viet Loan Dao Thi, et al.
Iscience|November 23, 2021
Fluvastatin mitigates SARS-CoV-2 infection in human lung cellsFrancisco J Zapatero-Belinchón, Rebecca Moeller, Lisa Lasswitz, et al.
Plos Pathogens|September 6, 2024
The triglyceride-synthesizing enzyme diacylglycerol acyltransferase 2 modulates the formation of the hepatitis C virus replication organelleIsabelle Reichert, Ji-Young Lee, Laura Weber, et al.
Gastroenterology|April 3, 2012
A plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytesSibylle Haid, Alexandra Novodomská, Juliane Gentzsch, et al.
Journal of Hepatology|April 16, 2020
C19orf66 is an interferon-induced inhibitor of HCV replication that restricts formation of the viral replication organelleVolker Kinast, Agnieszka Plociennikowska, Anggakusuma, et al.
Hepatology (Baltimore, Md.)|November 16, 2007
Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81Mirjam B Zeisel, George Koutsoudakis, Eva K Schnober, et al.
The Journal of Infectious Diseases|April 29, 2017
Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging CoronavirusesAnindya Siddharta, Stephanie Pfaender, Nathalie Jane Vielle, et al.
Npj Drug Discovery|June 30, 2026
Cystobactamid off-target profiling reveals favorable safety, superoxide reduction, and SCARB1 inhibition in eukaryotesTimo Risch, Benedikt Hellwinkel, Dietrich Mostert, et al.
Journal of Virology|March 4, 2021
Initial HCV infection of adult hepatocytes triggers a temporally structured transcriptional program containing diverse pro- and anti-viral elementsBirthe Tegtmeyer, Gabrielle Vieyres, Daniel Todt, et al.
Pageof 21

Showing results (171-180 of 210) with videos related to

Sort By:
Pageof 21
Hepatology (Baltimore, Md.)|May 23, 2015
Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of membranous web formationAnggakusuma, Inés Romero-Brey, Carola Berger, et al.
Hepatology Communications|February 7, 2018
Hepatitis E virus replication and interferon responses in human placental cellsLeonard Knegendorf, Svenja A Drave, Viet Loan Dao Thi, et al.
Iscience|November 23, 2021
Fluvastatin mitigates SARS-CoV-2 infection in human lung cellsFrancisco J Zapatero-Belinchón, Rebecca Moeller, Lisa Lasswitz, et al.
Plos Pathogens|September 6, 2024
The triglyceride-synthesizing enzyme diacylglycerol acyltransferase 2 modulates the formation of the hepatitis C virus replication organelleIsabelle Reichert, Ji-Young Lee, Laura Weber, et al.
Gastroenterology|April 3, 2012
A plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytesSibylle Haid, Alexandra Novodomská, Juliane Gentzsch, et al.
Journal of Hepatology|April 16, 2020
C19orf66 is an interferon-induced inhibitor of HCV replication that restricts formation of the viral replication organelleVolker Kinast, Agnieszka Plociennikowska, Anggakusuma, et al.
Hepatology (Baltimore, Md.)|November 16, 2007
Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81Mirjam B Zeisel, George Koutsoudakis, Eva K Schnober, et al.
The Journal of Infectious Diseases|April 29, 2017
Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging CoronavirusesAnindya Siddharta, Stephanie Pfaender, Nathalie Jane Vielle, et al.
Npj Drug Discovery|June 30, 2026
Cystobactamid off-target profiling reveals favorable safety, superoxide reduction, and SCARB1 inhibition in eukaryotesTimo Risch, Benedikt Hellwinkel, Dietrich Mostert, et al.
Journal of Virology|March 4, 2021
Initial HCV infection of adult hepatocytes triggers a temporally structured transcriptional program containing diverse pro- and anti-viral elementsBirthe Tegtmeyer, Gabrielle Vieyres, Daniel Todt, et al.
Pageof 21